{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:06:40Z","timestamp":1791173200125,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"crossref","award":["IIRG-07-59038"],"award-info":[{"award-number":["IIRG-07-59038"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["MOP-64382"],"award-info":[{"award-number":["MOP-64382"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of Science of Iran"},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.neurobiolaging.2013.08.029","type":"journal-article","created":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T05:31:05Z","timestamp":1381210265000},"page":"926-933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Increased pro\u2013nerve growth factor and decreased brain-derived neurotrophic factor in non\u2013Alzheimer's disease tauopathies"],"prefix":"10.1016","volume":"35","author":[{"given":"Jillian C.","family":"Belrose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raheleh","family":"Masoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadeta","family":"Michalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Fahnestock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00401-003-0671-8","article-title":"Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration","volume":"105","author":"Arai","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.nbd.2008.05.012","article-title":"Protective effect of BDNF against beta-amyloid induced neurotoxicity in\u00a0vitro and in\u00a0vivo in rats","volume":"31","author":"Arancibia","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2174\/156720511796717230","article-title":"Loss of medial septum cholinergic neurons in THY-Tau22 mouse model: what links with tau pathology?","volume":"8","author":"Belarbi","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/08977190410001723308","article-title":"Brain-derived neurotrophic factor","volume":"22","author":"Binder","year":"2004","journal-title":"Growth Factors"},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib5","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1073\/pnas.0901402106","article-title":"Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease","volume":"106","author":"Blurton-Jones","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1474-4422(05)70086-7","article-title":"Hope for AD with NGF gene-therapy trial","volume":"4","author":"Bradbury","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2174\/156720512800492468","article-title":"Hippocampal BDNF expression in a tau transgenic mouse model","volume":"9","author":"Burnouf","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib8","doi-asserted-by":"crossref","first-page":"e39566","DOI":"10.1371\/journal.pone.0039566","article-title":"Genetic knockdown of brain-derived neurotrophic factor in 3xTg-AD mice does not alter Abeta or tau pathology","volume":"7","author":"Castello","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0169-328X(97)00125-3","article-title":"Brain-derived neurotrophic factor is reduced in Alzheimer's disease","volume":"49","author":"Connor","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0306-4522(94)90462-6","article-title":"Reduced transport of [125I]nerve growth factor by cholinergic neurons and down-regulated TrkA expression in the medial septum of aged rats","volume":"62","author":"Cooper","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib11","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.20233","article-title":"Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease","volume":"56","author":"Counts","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib12","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00401-010-0716-8","article-title":"Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in\u00a0vivo","volume":"120","author":"Cowan","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib13","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2217\/fnl.11.44","article-title":"BDNF: The link between beta-amyloid and memory loss","volume":"6","author":"Fahnestock","year":"2011","journal-title":"Future Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1006\/mcne.2001.1016","article-title":"The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease","volume":"18","author":"Fahnestock","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0169-328X(96)00193-3","article-title":"Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex","volume":"42","author":"Fahnestock","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00005072-199907000-00007","article-title":"BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies","volume":"58","author":"Ferrer","year":"1999","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib17","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1046\/j.1471-4159.2002.01030.x","article-title":"A\u00a0new brain-derived neurotrophic factor transcript and decrease in brain-derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex","volume":"82","author":"Garzon","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib18","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1523\/JNEUROSCI.5053-06.2007","article-title":"Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells","volume":"27","author":"Garzon","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1471-4159.2006.03764.x","article-title":"Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease","volume":"97","author":"Ginsberg","year":"2006","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib20","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1523\/JNEUROSCI.17-10-03796.1997","article-title":"Learning impairment and cholinergic deafferentation after cortical nerve growth factor deprivation","volume":"17","author":"Gutierrez","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib22","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/archneur.57.6.846","article-title":"Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas","volume":"57","author":"Hock","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0169-328X(00)00023-1","article-title":"Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease","volume":"76","author":"Holsinger","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","article-title":"Neurotrophins: roles in neuronal development and function","volume":"24","author":"Huang","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-beta toxicity in alzheimer's disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"issue":"suppl. 1","key":"10.1016\/j.neurobiolaging.2013.08.029_bib26","first-page":"12","article-title":"Conditionally inducible tau mice\u2014designing a better mouse model of neurodegenerative diseases. Genes","volume":"7","author":"Janus","year":"2008","journal-title":"Brain and Behavior"},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib27","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1042\/BST0380993","article-title":"Pathways linking Abeta and tau pathologies","volume":"38","author":"LaFerla","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib28","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/hmg\/ddr492","article-title":"CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy","volume":"21","author":"Ljungberg","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1101\/lm.54603","article-title":"BDNF and activity-dependent synaptic modulation","volume":"10","author":"Lu","year":"2003","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0306-9877(96)90240-6","article-title":"The diseases of Alzheimer and Pick from the viewpoint of prevention","volume":"46","author":"Marcinkowski","year":"1996","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0169-328X(03)00003-2","article-title":"Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease","volume":"111","author":"Michalski","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib33","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neuron.2011.04.009","article-title":"The many faces of tau","volume":"70","author":"Morris","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib34","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/00001756-199505090-00028","article-title":"Nerve growth factor in Alzheimer's disease: defective retrograde transport to nucleus basalis","volume":"6","author":"Mufson","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib35","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2174\/156720507781788855","article-title":"Cholinotrophic molecular substrates of mild cognitive impairment in the elderly","volume":"4","author":"Mufson","year":"2007","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1042\/BST0330595","article-title":"Clinicopathological features of the tauopathies","volume":"33","author":"Murray","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nm.1912","article-title":"Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease","volume":"15","author":"Nagahara","year":"2009","journal-title":"Nature Med."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib38","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/00001756-200309150-00009","article-title":"Age-dependent changes in axonal transport and cellular distribution of Tau 1 in the rat basal forebrain neurons","volume":"14","author":"Niewiadomska","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1196\/annals.1342.026","article-title":"Altered cellular distribution of phospho-tau proteins coincides with impaired retrograde axonal transport in neurons of aged rats","volume":"1048","author":"Niewiadomska","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib40","doi-asserted-by":"crossref","first-page":"9321","DOI":"10.1523\/JNEUROSCI.4736-08.2009","article-title":"Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease","volume":"29","author":"Peng","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib41","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/j.1471-4159.2005.03135.x","article-title":"Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease","volume":"93","author":"Peng","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib42","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/jnen\/63.6.641","article-title":"Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease","volume":"63","author":"Peng","year":"2004","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib43","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0896-6273(91)90273-3","article-title":"BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease","volume":"7","author":"Phillips","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib44","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ygeno.2007.05.004","article-title":"Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters","volume":"90","author":"Pruunsild","year":"2007","journal-title":"Genomics"},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cell.2004.07.008","article-title":"Going the distance, or not, with neurotrophin signals","volume":"118","author":"Reichardt","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib46","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model","volume":"316","author":"Roberson","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib47","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/WNL.56.suppl_4.S3","article-title":"Pick's disease: a clinical overview","volume":"56","author":"Rossor","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2006.05.022","article-title":"Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration","volume":"51","author":"Salehi","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib49","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00702-003-0091-x","article-title":"Alzheimer's disease and NGF signaling","volume":"111","author":"Salehi","year":"2004","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib50","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.neurobiolaging.2003.08.002","article-title":"Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies","volume":"24","author":"Scheff","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"suppl 1","key":"10.1016\/j.neurobiolaging.2013.08.029_bib51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1601-183X.2007.00378.x","article-title":"Neurotrophic factors in Alzheimer's disease: role of axonal transport","volume":"7","author":"Schindowski","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib52","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1523\/JNEUROSCI.15-09-06213.1995","article-title":"Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis","volume":"15","author":"Scott","year":"1995","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib53","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0896-6273(00)81010-7","article-title":"Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism","volume":"20","author":"Tao","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib54","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib55","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1523\/JNEUROSCI.5463-03.2004","article-title":"Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons","volume":"24","author":"Tong","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib56","doi-asserted-by":"crossref","first-page":"17301","DOI":"10.1074\/jbc.M010450200","article-title":"Beta-amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival is not compromised","volume":"276","author":"Tong","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib57","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1194653","article-title":"Tau reduction prevents Abeta-induced defects in axonal transport","volume":"330","author":"Vossel","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib58","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1254\/jphs.CRJ05009X","article-title":"Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases","volume":"99","author":"Wada","year":"2005","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib59","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1523\/JNEUROSCI.21-03-01047.2001","article-title":"Elevation of nerve growth factor and antisense knockdown of TrkA receptor during contextual memory consolidation","volume":"21","author":"Woolf","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib60","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0024-3205(01)01461-8","article-title":"Role for brain-derived neurotrophic factor in learning and memory","volume":"70","author":"Yamada","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.neurobiolaging.2013.08.029_bib61","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1440-1789.2006.00743.x","article-title":"Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies","volume":"26","author":"Yoshida","year":"2006","journal-title":"Neuropathology"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013003746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013003746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:25:21Z","timestamp":1759317921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458013003746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0197458013003746"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.08.029","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased pro\u2013nerve growth factor and decreased brain-derived neurotrophic factor in non\u2013Alzheimer's disease tauopathies","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}